HB 7667 Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022

Health Advanced Technology And Technological Innovations Advisory Bodies Animal Protection And Human-animal Relationships Blood And Blood Diseases Business Records Cardiovascular And Respiratory Health Child Health Computer Security And Identity Theft Congressional Oversight Criminal Investigation, Prosecution, Interrogation Department Of Health And Human Services Drug Safety, Medical Device, And Laboratory Regulation Emergency Medical Services And Trauma Care Employee Hiring Evidence And Witnesses Executive Agency Funding And Structure Food And Drug Administration (fda) Genetics Government Employee Pay, Benefits, Personnel Management Government Information And Archives Government Studies And Investigations Health Care Coverage And Access Health Programs Administration And Funding Health Technology, Devices, Supplies Industrial Facilities Infectious And Parasitic Diseases Inflation And Prices Licensing And Registrations Manufacturing Marketing And Advertising Medical Research Minority Health Musculoskeletal And Skin Diseases Organ And Tissue Donation And Transplantation Performance Measurement Photography And Imaging Prescription Drugs Product Development And Innovation Public Participation And Lobbying Public-private Cooperation Radiation Research And Development Small Business User Charges And Fees